Clinical and biochemical evaluation of a new diuretic agent (Metolazone).
D000293:Adolescent; D000328:Adult; D000368:Aged; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007659:Ketones / Q000627:therapeutic use; D007674:Kidney Diseases / Q000188:drug therapy*; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011660:Pulmonary Heart Disease / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D004232:Diuretics; D007659:Ketones; D011799:Quinazolines; D013449:Sulfonamides